Clenbuterol 40mcg

Dragon Pharma Clenbuterol — 40mcg Beta-2 Adrenergic Thermogenic

Dragon Pharma Clenbuterol delivers 40 mcg of Clenbuterol Hydrochloride per tablet. This potent Beta-2 adrenergic agonist is engineered for athletes seeking aggressive fat reduction while preserving lean tissue during caloric restriction.

Unlike anabolic steroids, this compound operates through sympathetic nervous system activation. It elevates core temperature, accelerates basal metabolic rate, and enhances oxygen transport without direct androgen receptor interaction.

Overview

Clenbuterol Hydrochloride is a long-acting sympathomimetic amine with selective affinity for Beta-2 adrenergic receptors. Activation of these receptors triggers a cascade of cAMP-mediated metabolic events.

The compound stimulates mitochondrial uncoupling and lipolysis, forcing adipocytes to release stored fatty acids for energy expenditure. This creates a sustained thermogenic environment that persists for hours after administration.

As a bronchodilator, it relaxes smooth muscle in the airways. This improves pulmonary ventilation and oxygen diffusion capacity, supporting longer and more intense cardiovascular training sessions.

Mild anti-catabolic properties help protect contractile tissue during severe energy deficits. This preservation of muscle mass is critical for maintaining aesthetic density while stripping away subcutaneous fat.

Dragon Pharma subjects every production batch to independent analytical testing. Recent verification confirmed 39.56 mcg per tablet, ensuring precise micro-dosing for safe titration and predictable thermogenic response.

Benefits

• Intense Thermogenesis: Elevates core body temperature by stimulating mitochondrial heat production, forcing the body to burn additional calories continuously throughout the day.
• Accelerated Metabolism: Boosts basal metabolic rate by 10% or more, creating a significant energy deficit without requiring further caloric restriction.
• Appetite Modulation: Many users report reduced hunger signals, making strict dietary adherence and macronutrient compliance significantly more manageable.
• Enhanced Aerobic Output: Bronchodilation improves airway diameter and oxygen transfer, supporting superior endurance capacity during high-volume cardio sessions.
• Lean Tissue Preservation: Mild anti-catabolic activity helps maintain muscle fiber integrity and contractile protein mass during aggressive hypocaloric phases.

Main Features

• Precisely dosed 40 mcg tablets for controlled titration
• Long-acting Beta-2 adrenergic receptor agonist
• Sympathomimetic thermogenesis without androgenic activity
• Bronchodilatory effects supporting cardiovascular performance
• Mild anti-catabolic properties for muscle retention
• Independent laboratory verification of tablet potency

Ingredients

Each tablet contains 40 mcg of Clenbuterol Hydrochloride as the active pharmaceutical ingredient.

Inactive excipients include microcrystalline cellulose, lactose monohydrate, magnesium stearate, and pharmaceutical-grade binders to ensure tablet stability and consistent dissolution.

All raw materials undergo identity and purity validation prior to compression and packaging.

How to Use

Ingest tablets with water in the morning and early afternoon. Avoid administration after 4–5 PM to prevent insomnia and sleep disruption from the stimulant properties.

Split the daily total into two administrations to maintain stable plasma concentrations and moderate peak stimulant effects.

Store the container in a cool, dry environment between 15–25°C (59–77°F). Protect from moisture and direct light. Keep the desiccant pouch intact.

Dosage

The standard ramping protocol begins at 20 mcg on day one. This half-tablet dose assesses individual tolerance and cardiovascular response.

Increase by 20 mcg daily until reaching 120 mcg, typically by day six. This represents the common maximum for most male users.

Run the compound for 14 consecutive days, then discontinue for 14 days. This off-period allows Beta-2 receptor resensitization and restores full thermogenic efficacy.

Restart the cycle at 40–60 mcg after the two-week break. Tolerance will have reset, allowing for renewed fat-burning potency.

Female users typically require lower exposure, often maxing at 80–100 mcg daily. Always assess individual stimulant sensitivity before escalating.

Side Effects

Stimulant manifestations are common and dose-dependent. Hand tremors frequently appear during the first few days and typically subside as the body adapts.

Insomnia is a frequent complaint if doses are taken too late in the day. Strict morning and early-afternoon timing prevents sleep architecture disruption.

Anxiety and restlessness reflect heightened sympathetic nervous system activity. Users prone to panic or stress sensitivity should approach with caution.

Cardiovascular strain includes elevated resting heart rate and increased blood pressure. Monitor pulse regularly. If resting rate exceeds 100–110 beats per minute, reduce the dose immediately.

Heart palpitations or arrhythmia sensations require immediate discontinuation and medical evaluation.

Muscle cramps result from taurine and electrolyte depletion. Supplemental taurine at 3–5 grams daily and adequate potassium intake are mandatory protective measures.

Receptor downregulation occurs with continuous use. The two-week on, two-week off protocol is mandatory to prevent pharmacological tolerance and maintain efficacy.

Safety Information

This product is intended exclusively for research purposes and use by qualified adults under appropriate supervision. It is not suitable for minors, pregnant or nursing women, or individuals with pre-existing cardiovascular, hypertensive, or thyroid conditions.

Regular monitoring of resting heart rate and blood pressure is essential throughout the active phase. Discontinue if either metric becomes dangerously elevated.

Maintain adequate hydration and electrolyte balance. Taurine and potassium supplementation prevent painful cramping and support muscular function.

Avoid all other stimulants including caffeine, ephedrine, and pre-workout supplements during the active phase. Combining sympathomimetics amplifies cardiovascular risk exponentially.

Discontinue immediately and seek medical evaluation if chest pain, severe palpitations, shortness of breath, or persistent headaches develop.

Never exceed 14 consecutive days of administration without a minimum 14-day washout period.